Search results “Cryptogenic ischemic stroke definition who”
Cryptogenic Strokes
Dr. Mary Ann Bauman tells us more about cryptogenic strokes and the new patient guide.
Views: 570 KMTV 3 News Now
What Is A Cryptogenic Stroke?
A stroke happens once a vessel within the brain is suddenly blocked or bursts, leading to harm to the brain tissue. The bulk of all strokes area unit anaemia, which suggests they occur as a result of AN obstruction, like a blood clot, inside the vessel. In this video, I describe what a cryptogenic stroke and its connection with atrial fibrillation is. Ask a question at “AFib Fridays” on my Facebook page at https://www.facebook.com/DoctorAFib/ Join our channel by subscribing here. If you have enjoyed our video, please like it and leave a comment about what other videos you may be interested in. Your help in creating great, relevant content is greatly appreciated.
Views: 110 Dr. AFib
Ischemic stroke causes symptoms diagnosis treatment pathology
In an ischemic stroke, blood supply to part of the brain is decreased, leading to dysfunction of the brain tissue in that area. There are four reasons why this might happen: Thrombosis (obstruction of a blood vessel by a blood clot forming locally) Embolism (obstruction due to an embolusfrom elsewhere in the body), Systemic hypoperfusion (general decrease in blood supply, e.g., in shock) Cerebral venous sinus thrombosis. A stroke without an obvious explanation is termed cryptogenic (of unknown origin); this constitutes 30-40% of all ischemic strokes. There are various classification systems for acute ischemic stroke. The Oxford Community Stroke Project classification (OCSP, also known as the Bamford or Oxford classification) relies primarily on the initial symptoms; based on the extent of the symptoms, the stroke episode is classified as total anterior circulation infarct (TACI), partial anterior circulation infarct (PACI), lacunar infarct (LACI) or posterior circulation infarct(POCI). These four entities predict the extent of the stroke, the area of the brain that is affected, the underlying cause, and the prognosis. The TOAST (Trial of Org 10172 in Acute Stroke Treatment) classification is based on clinical symptoms as well as results of further investigations; on this basis, a stroke is classified as being due to (1) thrombosis or embolism due to atherosclerosis of a large artery, (2) an embolism originating in the heart, (3) complete blockage of a small blood vessel, (4) other determined cause, (5) undetermined cause (two possible causes, no cause identified, or incomplete investigation).Users of stimulants, such as cocaine and methamphetamine are at a high risk for ischemic strokes. There are two main types of hemorrhagic stroke: Intracerebral hemorrhage, which is basically bleeding within the brain itself (when an artery in the brain bursts, flooding the surrounding tissue with blood), due to either intraparenchymal hemorrhage (bleeding within the brain tissue) or intraventricular hemorrhage (bleeding within the brain's ventricular system). Subarachnoid hemorrhage, which is basically bleeding that occurs outside of the brain tissue but still within the skull, and precisely between the arachnoid mater and pia mater (the delicate innermost layer of the three layers of the meninges that surround the brain). The above two main types of hemorrhagic stroke are also two different forms of intracranial hemorrhage, which is the accumulation of blood anywhere within the cranial vault; but the other forms of intracranial hemorrhage, such as epidural hematoma (bleeding between the skull and the dura mater, which is the thick outermostlayer of the meninges that surround the brain) and subdural hematoma (bleeding in the subdural space), are not considered "hemorrhagic strokes". Hemorrhagic strokes may occur on the background of alterations to the blood vessels in the brain, such as cerebral amyloid angiopathy, cerebral arteriovenous malformation and an intracranial aneurysm, which can cause intraparenchymal or subarachnoid hemorrhage.[citation needed] In addition to neurological impairment, hemorrhagic strokes usually cause specific symptoms (for instance, subarachnoid hemorrhage classically causes a severe headache known as a thunderclap headache) or reveal evidence of a previous head injury
Cryptogenic Stroke Multidisciplinary Pathways Video
Learn about a collaborative care approach and model to better support stroke survivors who suffer a stroke of an unknown/unexplained cause; also known as cryptogenic stroke.
Cryptogenic Stroke - Sydney's Story
Cryptogenic Stroke - This is a common diagnosis in children and young adults with stroke.  It simply means that the cause for stroke is unknown.  While in some cases, even after thorough investigation, the cause may remain unknown, stroke experts at referral centers may offer investigations that find a cause that was missed.  Sometimes this is very important for management strategies to prevent recurrent stroke.  In children, a cause of stroke can be identified in most cases.  Our Foundation wants to provide education to local hospitals to improve diagnosis, treatment and rehabilitation of young stroke patients.   Let's work together to create solutions for families not problems.  A ray of hope is a powerful treatment for the despair that comes with a new diagnosis of stroke.
2015 American Stroke Association Cryptogenic Stroke Conference
Highlights from the 2015 American Stroke Association Cryptogenic Stroke Conference in Washington, D.C. – Learn more about what the American Stroke Association is doing to advance the diagnosis and treatment of strokes of unknown etiology.
Cryptogenic Stroke Patients
About one in four strokes in the U.S. are “cryptogenic” meaning the cause is undetermined. Statistics show cryptogenic stroke patients have reason to be concerned: A prior stroke is the number one risk factor for a second stroke. According to a new survey by the American Heart Association/American Stroke Association more than 50 percent of stroke patients and family caregivers report feeling anxious and frustrated when the cause of stroke is not detected.
Views: 71 KGUN9
Improving Outcomes in Stroke
Trials have shown that endovascular thrombectomy within 6 hours after the onset of ischemic stroke symptoms has a clinical benefit, but the effect after more than 6 hours is not known. New research findings are summarized in a short video. See the related NEJM article: http://www.nejm.org/doi/full/10.1056/NEJMoa1706442
Views: 2925 NEJMvideo
Understanding Stroke
Stroke is the third leading cause of death in America. Dr. Melvin Wichter, a neurologist at Advocate Christ Medical Center, discusses the different types of stroke and how a stroke differs from a heart attack.
Views: 325 AdvocateHealthCare
Dr. Lee MacDonald explains the link between PFO and Stroke
Lee MacDonald, MD is an interventional cardiologist with South Denver Cardiology Associates and briefly describes the link between stroke and PFO (Patent Foramen Ovale).
Genetic Causes of Stroke, Wozniak, 1/3
Marcella Wozniak, MD, PhD Associate Professor of Neurology University of Maryland School of Medicine University of Maryland Medical Center Keynote Speaker
Views: 123 delamed302
American Stroke Association’s Cryptogenic Stroke Initiative
An estimated one-third (200,000) of ischemic strokes in the U.S. are classified as cryptogenic (unknown etiology). Recognizing the opportunities to better serve the cryptogenic stroke population, the American Heart Association/American Stroke Association’s Cryptogenic Stroke Initiative, sponsored by Medtronic, focus is to increase the awareness of cryptogenic stroke as a national public health issue, to drive awareness of underlying risk factors that contribute to cryptogenic stroke, drive accountability of the multidisciplinary team members to improve care for these patients, and prevent a recurrent stroke, thereby decreasing overall stroke mortality and disability from stroke. For more information, go to StrokeAssociation.org/CS.
Ischemic Stroke
Views: 179 aim900
Can a Biomarker Predict Which Ischemic Stroke Patients Benefit From Different Therapies?
From the 2013 AAN Annual Meeting: Can a biomarker predict which ischemic stroke patients benefit from anticoagulants or antiplatelet agents? In a video interview, Neurology Today's Editor-in-Chief Steven P. Ringel, MD, and Associate Editor Robert Holloway, MD, discuss the key clinical takeaways from the latest analysis of data from the Antiphospholipid Antibodies and Stroke Study and the Warfarin-Aspirin Recurrent Stroke Study. The full story here: http://bit.ly/1cZcek5
Views: 117 Neurology Today
Stroke Survivor Story: Overcoming the Unknown
Dan Merritt had a stroke while waiting for a doctor’s appointment on Halloween and then a second later that night. After a third cryptogenic stroke, finding answers became the trick. Learn more about cryptogenic stroke at www.StrokeAssociation.org/CS
What Is An Embolic Stroke?
Therefore, it is likely that the stroke was due to af. Googleusercontent search. Embolic stroke embolic symptoms, treatments, and long term outlook. Cardioembolic stroke overview cardioembolic stroke, of symptoms and diagnosis uptodate. Stroke symptoms and causes mayo clinicinternet stroke center. Stroke happens suddenly, often without warning embolic strokes are also ischemic. Uw medicine embolic stroke symptoms, treatments, and long term outlook healthline health slideshow symptoms url? Q webcache. Cardioembolic stroke an update on etiology, diagnosis and secondary to cardiogenic embolism symptoms, cardioembolic clinical features, specific cardiac disorders thrombotic guide causes, symptoms treatment options. Ischemic ischemic stroke can be divided into two main types thrombotic and embolic may 30, 2017 is a type of stroke, in which the clot formed elsewhere body travels through blood stream, to jan 20, 2015 cardioembolic largely preventable, warranting efforts at primary prevention for major risk sources. Eventually, the clot lodges in a blood vessel and blocks flow of blood, causing stroke nov 16, 2016 an embolic is type ischemic. Ischemic strokes (clots) american stroke association. Ischemic strokes can happen if an artery to the brain becomes blocked. Embolic stroke symptoms, treatments, and outlook healthlinetypes of. An embolic stroke occurs when a blood clot or other debris forms away from your brain commonly in heart and is swept through an ischemic artery the becomes blocked. Johns hopkins medicine health library. A cardioembolic stroke occurs when the heart pumps feb 20, 2007 secondary to cardiogenic embolism is a loss of brain function caused by blood clots that develop in and travel this article provides reader with an overview up date clinical features, specific cardiac disorders prognosis another type embolic also clot. Lacunar strokes, which are treated with may 11, 2016 for stroke awareness month, lets see the link between blood clots and embolic an issue that affects one american every 40 seconds esus, previously known as cryptogenic stroke, is a clinical entity refers to patients aetiology of embolism remains. An embolic stroke occurs when a blood clot that forms elsewhere in the body (embolus) breaks loose and travels to brain via bloodstream. They are caused by blockage of one the arteries to brain a blood clot that has formed elsewhere (usually in learn about different types strokes including ischemic, thrombotic, embolic, and hemorrhagic strokes, intracerebral subarachnoid hemorrhages embolic stroke. Embolic stroke (mgh service). Identification of embolic stroke patterns by diffusion weighted mri stroke, atrial fibrillation, and microbleeds awareness month blood clots the vein introduction thrombosis adviser. Prior to making any medical decisions, please view our disclaimerfeatures apr 26, 2017 ischemic strokes (clots) occur as a result of an obstruction within blood cerebral embolism refers generally clot that forms at
Views: 206 I Question You
#10 Cryptogenic stroke: Solving the unsolved
Diagnostic dilemmas, cryptogenic infarcts account for almost a third of all stroke subtypes. But if you break it down, it's really not so complicated. In our tenth episode, Dr. Noah Levinson gets some insight into the diagnostic approach of this confounding condition. BrainWaves podcasts and online content are intended for medical education only and should not be used to guide medical decision making in routine clinical practice. Any cases discussed in this episode are fictional and do not contain any patient health identifying information. The content in this episode was vetted and approved by Michael Mullen. REFERENCES 1. Hart RG, Diener HC, Coutts SB, Easton JD, Granger CB, O'Donnell MJ, Sacco RL, Connolly SJ and Cryptogenic Stroke EIWG. Embolic strokes of undetermined source: the case for a new clinical construct. The Lancet Neurology. 2014;13:429-38. 2. Jacobs BS, Boden-Albala B, Lin IF and Sacco RL. Stroke in the young in the northern Manhattan stroke study. Stroke; a journal of cerebral circulation. 2002;33:2789-93. 3. Putaala J, Metso AJ, Metso TM, Konkola N, Kraemer Y, Haapaniemi E, Kaste M and Tatlisumak T. Analysis of 1008 consecutive patients aged 15 to 49 with first-ever ischemic stroke: the Helsinki young stroke registry. Stroke; a journal of cerebral circulation. 2009;40:1195-203. 4. Bang OY, Lee PH, Joo SY, Lee JS, Joo IS and Huh K. Frequency and mechanisms of stroke recurrence after cryptogenic stroke. Annals of neurology. 2003;54:227-34.
Views: 11 BrainWaves Staff
Stroke syndromes OCSP  Etiology TOAST
This is a Learning in 10 voice annotated presentation (VAP) on Stroke syndromes OCSP Etiology TOAST To learn more about Learning in 10 (LIT), please visit learningin10.com. -- Learning in 10 (LIT) Reviews is a collection of 10-minute, user-friendly video lectures covering topics in the United States Medical Licensing Exam (USMLE) Step 2CK examination. LIT Reviews can be used by medical students to supplement their lecture materials. LIT Reviews have been created by world-class clinical faculty and each video undergoes a peer-review process to ensure accuracy of information.
Views: 235 Learning in 10
Dr Subhash Kaul - PFO Closure in ESUS Stroke? (Yes)
Should closure of PFO be recommended treatment and standard care of patient with ESUS ? PFO is associated with cryptogenic stroke (stroke of unclear etiology). PFO is present in 20-25% of the adult population, but in 40% of adults with cryptogenic stroke.  Despite the association between PFO and cryptogenic stroke, three early randomized clinical trials (CLOSURE I, PC trial, and RESPECT short-term) did not show a clear benefit of PFO closure for secondary stroke prevention. In March 2016, a meta-analysis of patient-level data from CLOSURE I, PC, and RESPECT was published. This meta-analysis found that PFO closure was superior to medical therapy for the prevention of recurrent ischemic stroke. When the analysis was restricted to the trials in which only the Amplatzer PFO occluder device was used (PC and RESPECT), the benefit appeared even greater. Should closure of PFO be recommended treatment and standard care of patient with ESUS ? Dr. Subhash Kaul MD (Gen Medicine), DM (Neurology), FRCP(Glasgow), FAAN (USA)Sr. Consultant Neurologist Qualifications: MBBS, Govt. Medical College, Srinagar, 1975-80MD (Gen.Medicine), Govt.Medical College, Srinagar, 1980-85DM (Neurology), PGIMER, Chandigarh, 1985-90Stroke Fellowship (NIH Maryland, USA), 1994-1996 Experience : Professor of Neurology, Head Unit II, NIMS, Hyderabad 2000-04 Head, Department of Neurology, NIMS, Hyderabad 2004-18 Dean Incharge, NIMS, Hyderabad 2015-18 Publications: 120 in National and International journals Awards And Honors: State Teachers Award, Government of Telengana 2017Past President, Andhra Pradesh Neuroscientists AssociationPast President, Indian Stroke AssociationPast President, Indian Academy of NeurologyFellow of Indian Academy of NeurologyFellow of American Academy of NeurologyFellow of American Stroke AssociationFellow of Royal College of Physicians (Glasgow)
Views: 62 Stroke Neurology
Stroke (for patients & families)
Find more videos at http://osms.it/more. Study better with Osmosis Prime. Retain more of what you’re learning, gain a deeper understanding of key concepts, and feel more prepared for your courses and exams. Sign up for a free trial at http://osms.it/more. Subscribe to our Youtube channel at http://osms.it/subscribe. Get early access to our upcoming video releases, practice questions, giveaways and more when you follow us on social: Facebook: http://osms.it/facebook Twitter: http://osms.it/twitter Instagram: http://osms.it/instagram Thank you to our Patreon supporters: Sumant Nanduri Omar Berrios Alex Wright Suzanne Peek Arfan Azam Mingli Féng Osmosis Vision: Empowering the world’s caregivers with the best learning experience possible.
Views: 25310 Osmosis
New Updates in Ischemic Stroke and TIA
This is a Grand Rounds from the Department of Emergency Medicine at the University of Ottawa. The presenter is Dr. Simeon Mitchell. The presenter has no conflicts of interest to declare. The views and opinions expressed on this video are those of Dr. Mitchell's and do not necessarily reflect the views and opinions of The Department of Emergency Medicine at the University of Ottawa or The Ottawa Hospital. This video should not be construed as personal medical advice and is not intended to replace medical advice offered by physicians.
Views: 3132 EM Ottawa
Prof M V Padma (AIIMS) - PFO Closure in ESUS ? (No)
Should closure of PFO be recommended treatment and standard care of patient with ESUS ? PFO is associated with cryptogenic stroke (stroke of unclear etiology). PFO is present in 20-25% of the adult population, but in 40% of adults with cryptogenic stroke. Despite the association between PFO and cryptogenic stroke, three early randomized clinical trials (CLOSURE I, PC trial, and RESPECT short-term) did not show a clear benefit of PFO closure for secondary stroke prevention. In March 2016, a meta-analysis of patient-level data from CLOSURE I, PC, and RESPECT was published. This meta-analysis found that PFO closure was superior to medical therapy for the prevention of recurrent ischemic stroke. When the analysis was restricted to the trials in which only the Amplatzer PFO occluder device was used (PC and RESPECT), the benefit appeared even greater. Should closure of PFO be recommended treatment and standard care of patient with ESUS ? Prof. M V Padma Srivastava(MBBS, MD, DM. FAMS, F.N.A.Sc) Dr Padma Srivastava has a primary area of interest in Stroke, Vascular Dementia and Multiple Sclerosis besides actively participating in the Epilepsy Program at AIIMS. She initiated the Hyperacute Reperfusion strategies including the thrombolysis program  for acute ischemic stroke at AIIMS. She is currently the President of the Indian Stroke Association and was instrumental in formulating the India Stroke Guidelines which are now endorsed by the ISA. She has been the visiting professor to the Department of Neurology, UMASS, Boston. She has more than 200 publications in peer reviewed publications including journals and chapters in books. She is also the recipient of the prestigious Vimla Virmani Oration,  Achanta Laxmipathy Oration from  NAMS, K.L.Wig Oratin from API & Fellowship from NAMS and NASI.
Views: 56 Stroke Neurology
PFO Stroke Animation
Dr. Robert J. Cubeddu is the Medical Director of the Structural and Adult Congenital Heart Program at Aventura Hospital and Medical Center, Miami, Florida. Dr. Cubeddu trained at the Massachusetts General Hospital in Harvard Medical School where he acquired expertise training in minimally invasive catheter-based technology to treat multiple structural heart related conditions. In this interview we had the honor to meet Dr. Cubeddu and speak with him about PFO closure. Q: What is a PFO? A: A PFO is the abbreviated term for "patent foramen ovale"; a small "tunnel-like" hole or communication present along the septal wall that separates the upper two chambers of the heart. Typically this hole closes shortly after birth, however in some people the hole may never close and can remain open throughout adulthood. Q: How many people have a PFO? A: It is estimated that approximately 20% of adults have a PFO, that is 1 in 5 people. In most cases, having a PFO is medically not important. However, in a small percentage of patients with a PFO it may be associated with the development of stroke and/or migraine headaches. Q: How do you check for PFO? A: A PFO can be diagnosed with a conventional echocardiogram using the administration of "agitated saline" . This diagnostic test is simple, routine, non-invasive, and takes approximately 10-15 minutes. Q: Who should be checked for a PFO? A: Patients with unexplained strokes or history of debilitating migraine headaches should be evaluated for a PFO. Q: Can patients have their PFO closed? A: Yes, PFO closure is possible and recommended in some patients. The objective of closing the PFO is to prevent future strokes in patients who have not had success with blood thinners or simply cannot take them. Q: How can patients have their PFO closed? A: Nowadays, PFO closure may be performed by skilled operators with expertise training in structural heart interventions. The procedure takes approximately 1-2 hours and is performed through a minimally invasive 5 mm incision at the level of the groin under local anesthesia. A long catheter is carefully maneuvered up to the heart across the PFO. A special double-umbrella device is then delivered through this catheter to close the PFO successfully. The procedure is pain-free. Recovery times are short with nearly all patients discharged by the following morning. Q: Are migraine sufferers considered candidates for closure? A: Currently the evidence to support PFO closure in patients with migraines is relatively controversial. However in some patients with disabling migraines and who are unresponsive to medical therapy, PFO closure may be considered. Q: Tell us about recent cases you've conducted? A: We have had many stroke victims referred for PFO closure. I am happy to say that our experience has been 100% success. For more information about PFO closure, and other innovative catheter-based structural heart disease interventions including: • Percutaneous valve replacement. • Repair of congenital heart defects. • Alcohol septal ablation. • And other stroke prevention strategies in patients with atrial fibrillation contact Dr. Cubeddu at 786-428-1059 or visit us at http://aventura.floridaheartandvascular.com , serving Aventura and surrounding Miami-Dade and Broward county. ================================================
Views: 36738 AHMCaventura
Tia's story
Success stories.
Views: 142 AlphaProjectSD
5th Annual Neuroscience Symposium | Dr. Srinath Kadimi | Cryptogenic Stroke
5th Annual Neuroscience Symposium Topic: Cryptogenic Stroke Speaker: Srinath Kadimi, MD Presented by: St. Mary's Medical Center - West Palm Beach, FL Palm Beach Neuroscience Institute - West Palm Beach, FL Palm Beach Children Hospital at St. Mary's Medical Center
Views: 231 TFPS Docs
Stroke gene discovered
Ischemic stroke is the second leading cause of death worldwide. Only one moderately effective therapy exists, albeit with contraindications that exclude 90% of the patients. This medical need contrasts with a high failure rate of more than 1,000 pre-clinical drug candidates for stroke therapies. Thus, there is a need for translatable mechanisms of neuroprotection and more rigid thresholds of relevance in pre-clinical stroke models. One such candidate mechanism is oxidative stress. However, antioxidant approaches have failed in clinical trials, and the significant sources of oxidative stress in stroke are unknown. We here identify NADPH oxidase type 4 (NOX4) as a major source of oxidative stress and an effective therapeutic target in acute stroke. Upon ischemia, NOX4 was induced in human and mouse brain. Mice deficient in NOX4 (Nox42/2) of either sex, but not those deficient for NOX1 or NOX2, were largely protected from oxidative stress, blood-brain-barrier leakage, and neuronal apoptosis, after both transient and permanent cerebral ischemia. This effect was independent of age, as elderly mice were equally protected. Restoration of oxidative stress reversed the stroke-protective phenotype in Nox42/2 mice. Application of the only validated low-molecular-weight pharmacological NADPH oxidase inhibitor, VAS2870, several hours after ischemia was as protective as deleting NOX4. The extent of neuroprotection was exceptional, resulting in significantly improved long-term neurological functions and reduced mortality. NOX4 therefore represents a major source of oxidative stress and novel class of drug target for stroke therapy. Citation: Kleinschnitz C, Grund H, Wingler K, Armitage ME, Jones E, et al. (2010) Post-Stroke Inhibition of Induced NADPH Oxidase Type 4 Prevents Oxidative Stress and Neurodegeneration. PLoS Biol 8(9): e1000479. doi:10.1371/journal.pbio.1000479
Views: 734 Harald Schmidt
The relationship between AFIB and stroke
Dr. Harish Manyam, Director of Cardiovascular Research and Head of the Atrial Fibrillation Center with UT Erlanger Cardiology, describes how certain types of AFIB can increase the risk of stroke. He also describes the joint effort with UT Erlanger Neurologist Dr. Thomas Devlin to create the CVA Clinic to help identify possible abnormal heart rhythms and/or vascular issues in patients who have suffered a cryptogenic stroke.
Views: 209 ErlangerHealth
San Diego Health: Preventing and Treating Strokes
Host Susan Taylor and Dr. Kalafut discuss the risk factors, prevention, diagnosis, and treatment of strokes. Learn more or find a neurologist: www.scripps.org/6543yt 0:50 - What is a stroke? 1:04 - What causes a stroke? 1:16 - What are the symptoms of a stroke? 1:29 - Do all symptoms of a stroke come in a cluster? 1:54 - Are there different types of strokes? 2:31 - What is a transient ischemic attack? 3:34 - What is a cryptogenic stroke? 5:39 - What is the age for someone at risk for a cryptogenic stroke? 6:32 - Why is time so critical in diagnosing a stroke? 7:45 - When you're having a stroke, should you call 911 and have an ambulance come or should you drive yourself to the hospital? 8:17 - Who is at risk for having a stroke? 8:36 - What tests are used to diagnose a stroke? 9:59 - What is the likelihood of having a second stroke? 10:57 - What does FAST stand for? 11:45 - If you have a stroke, what is the treatment? 12:45 - Where does family history stand as a risk factor? 13:00 - Who makes up the stroke rehabilitation team? 13:37 - How long does it take to come back from a stroke? 13:56 - Are strokes largely preventable? 14:31 - What is the difference between a primary and a comprehensive stroke center? 15:35 - What is the Gold Plus status for stroke hospitals?
Views: 11 Scripps Health
PFO Predicts Stroke for Patients with Endocardial Leads
In Circulation, researchers report whether a PFO increases the risk of stroke or TIA in patients with endocardial leads.
Hot Topics in Secondary Stroke Prevention
Presented by: Dr. Ted Wein Assistant Professor of Neurology and Neurosurgery McGill University Stroke Prevention Clinic Montreal General Hospital The Sixth Edition of the CSBPR Secondary Prevention of Stroke Guidelines have been published. Recent trial releases have impacted changes to the guidelines which include lipid management, diabetes and stroke, and patent foramen ovale (PFO) and stroke management. During this webinar the evidence and changes to the guidelines related to these topics will be discussed. Participants of this program will be able to: 1. Explain lipid management and diabetes and stroke CSBPR guideline changes from recent clinical trial releases. 2. Describe the evidence from the Close and Reduce trial, discussing PFO management and stroke, and the revised recommendations due to the trial’s results. 3. Discuss challenges and approaches to secondary prevention of stroke in complex patients with multimorbidities. 4. Engage participants in the webinar through a question and answer session at the end of the presentation. Please complete a brief evaluation for this session: http://bit.ly/2hHMHDF
Views: 685 Heart and Stroke
Economic Value of Reveal LINQ™ Insertable Cardiac Monitor in Cryptogenic Stroke Patients
This video is directed to Health Care Professionals across Europe and describes the Economic Value of the Reveal LINQ™ Insertable Cardiac Monitor (ICM). The Reveal LINQ™ is an innovative and powerful solution with proven clinical effectiveness and economic value to increase patient quality of life and reduce stroke-related costs. For more information visit us at www.medtronicdiagnostics.com
Views: 93 MedtronicEurope
Atherosclerosis and stroke - N Bornstein
This video was recorded during the ESC Heart & Brain workshop course held at Charles University in Prague, Czech Republic. The goal of this first edition of this workshop was to bring together leading experts in the field of stroke and cardiologists, neurologists, radiologists, surgeons and other specialists to learn from each other. Find out more about the ESC Council on Stroke: https://www.escardio.org/Councils/Council-on-Stroke?hit=youtube
PFO closure for cryptogenic stroke CATCD 2008
Saibal Kar MD, Mark Reisman MD, Greg Fontana MD, and Jonathan Tobis MD discuss PFO closure to treat cryptogenic stroke at the 2008 Controversies and Advances in the Treatment of Cardiovascular Disease in Los Angles.
Views: 2832 CardiacControversies
Carotid Dissection Stroke - Laressa's Story
Our mission is to educate doctors throughout the United States but at Children's Stroke Foundation if we can teach anyone who listens, we will. We will post a series of videos every other month about the different causes we know cause Stroke in children, teens and young adults. Each one will be short but informative. This first video is "Stroke by Accident" - an awful experience for this little girl whose strokes could have been avoided. But through this accident Children's Stroke Foundation was founded! Children's Stroke Foundation exists now to help families and promote stroke education among the U.S. medical network. "The world is a university and everyone in it is a teacher. Make sure when you wake up in the morning you go to school" -Bishop T.D. Jakes.
Mercy Stroke Coordinator Discusses TIAs
Diane Handler, Mercy Medical Center Stroke Coordinator, discusses Transient Ischemic Attacks (TIAs) with Ashley Hinson of KCRG-TV9 News on April 9, 2012. TIAs are warning signs that a major stroke could occur soon. Learn about risk factors, symptoms and what to do if you have one.
Views: 190 Mercy Cedar Rapids
Atrial fibrillation, or Afib, is an important risk factor for stroke. However, the risk can be significantly reduced with the use of medication known as blood thinners or anticoagulants. Blood thinners form the foundation for stroke prevention when a patient has Afib. In properly selected patients they are effective and easy to use. Choosing the most appropriate blood thinner requires a careful discussion with your doctor. In rare situations such as an emergency, the blood thinning effect may need to be reversed. Examples of situations include serious injury caused by a car accident or when emergency surgery is required, such as for a ruptured appendix or broken hip. There are different ways to reverse the blood thinning effect, depending on which blood thinner the patient is taking. There are many causes of stroke, but the vast majority are caused by a blood clot that interrupts blood flow to a part of the brain. This can result in a sudden loss of strength, feeling, vision or speech. These signs and symptoms can be temporary, resulting in a “mini stroke,” or transient ischemic attack (TIA), or they can result in permanent disability. Therefore, anyone experiencing the warning signs of stroke should be assessed for immediate stroke treatment at the closest emergency department. If you know someone who would benefit from this information, please share this video: https://youtu.be/3wQBmrQblu0
Views: 276560 Red-Fish
Julie's Stroke Survivor Story: From her First Signs to Recovery
Watch Julie's story and the tremendous people who helped her get home to her kids 4 days after having a massive stroke!
New Stroke Classifications and What They Mean (ALAN B. LUMSDEN, MD) September 20, 2017
"New Stroke Classifications and What They Mean” Houston Methodist DeBakey Heart & Vascular Center, Cardiovascular Research Seminar featuring ALAN B. LUMSDEN, MD as he discusses "New Stroke Classifications and What They Mean”. Speaker: ALAN B. LUMSDEN, MD Presentation: ZSOLT GARAMI, MD
Treatment of a patient with intractable Migraine Headache
Severe Migraine headache in some patients is due to a small hole in the heart( Patent Foramen Ovale-PFO) present since birth. Closure of this hole non-surgically by a device called PFO device cures this headache. The same phenomenon is involved in brain stoke in young patients( Ischemic stroke) below age 45 years. These patients require evaluation for PFO and device closure.
Views: 241 scsinhacardio
An Inspiring Comeback: A Stroke Survivor Story
If you have trouble getting motivated to work out, take your inspiration from Christina Goyette. The 38-year-old stroke survivor pumps iron everyday. She went from being paralyzed for eight weeks to being more than 90% recovered from her stroke. Christina says, "Renown helped me tremendously with their staff that always gave me hope that I will make it - that I will walk again, that I will talk again and I will eat again." Now she is determined to get full movement back in the left side of her body. She is truly an inspiration. renown.org
Views: 22708 Renown Health
Cryptogenic Organizing Pneumonia - Cure Healing Rife Frequency
Cryptogenic Organizing Pneumonia - Cure Healing Rife Frequency by HealingBox Brainwaves (Binaural Sound Therapy) Cryptogenic organizing pneumonia (COP), also known as bronchiolitis obliterans organizing pneumonia (BOOP), is an inflammation of the bronchioles (bronchiolitis and surrounding tissue in the lungs. It should not be confused with bronchiolitis obliterans, a form of non-infectious pneumonia. It is often a complication of an existing chronic inflammatory disease such as rheumatoid arthritis, dermatomyositis, or it can be a side effect of certain medications such as amiodarone. The clinical features and radiological imaging resemble infectious pneumonia. However, diagnosis is suspected after there is no response to multiple antibiotics, and blood and sputum cultures are negative for organisms. Please Subscribe us for Daily Updates and more Music... https://youtu.be/UAfBxgue6Zk Find Us on social Media: https://twitter.com/HealingboxT https://plus.google.com/105980955065397573178 https://www.facebook.com/HealingBoxBrainwaves/
MR WITNESS: Expanding TPA for Unwitnessed Stroke?
Colin Derdeyn, MD interviews Lee Schwamm, MD about the results of the MR WITNESS trial, which he presented for ISC 2016 in Los Angeles. 2/19/2016 | ISC 2016 | Colin Derdeyn, MD, Lee Schwamm, MD
Views: 540 AHAScienceNews
Young Adults Could be at Risk for Stroke | UCLA Health
Jennifer Reilly was 28 years old when she began experiencing some odd symptoms. Half of her left hand went numb. She could move her fingers, but she couldn’t feel anything on the outer part of that hand. Because she was so young, Reilly just assumed it was nothing. She was wrong. She was having a stroke. The numbness recurred off and on for several days. Then one night she had a piercing headache, an uncommon event for her. She mentioned her symptoms to a work colleague, who urged her to see a doctor. “I didn’t know I was having a stroke at the time,” said Reilly, now 35. “I just assumed I was a healthy, normal 28-year-old.” Reilly saw several doctors and finally landed at UCLA in the neurology department, where she said Dr. David Liebeskind, professor of neurology, director of Outpatient Stroke and Neurovascular Programs and director of the Neurovascular Imaging Research Core. After a battery of tests, Reilly was diagnosed with Moyamoya disease - a rare, progressive cerebrovascular disorder caused by blocked arteries at the base of the brain, cutting off blood flow. One of the first symptoms of Moyamoya is recurrent transient ischemic attacks, or TIAs, commonly referred to as “mini-strokes,” exactly what Reilly was experiencing. She had no idea the danger she was in, Liebeskind said. “The worst and a very likely possibility is that she would have had a significant stroke,” he said, one that could have been extremely debilitating or even fatal. Reilly was referred to Dr. Neil Martin, chair of neurosurgery at Ronald Reagan UCLA Medical Center and head of the neurovascular surgery section. What he told Jennifer was alarming.
Views: 1128 UCLA Health
International Academy of Cardiology: J. Rod Gimble, M.D.: CRYPTOGENIC STROKE - COULD LONG TERM
CRYPTOGENIC STROKE - COULD LONG TERM CARDIAC MONITORING UNCOVER THE CAUSE J. Rod Gimbel, M.D. Knoxville, TN, USA Presented at the: International Academy of Cardiology 18th World Congress on Heart Disease Annual Scientific Sessions 2013 Vancouver, B.C., Canada July 26-29, 2013 Congress Chairman: Asher Kimchi, M.D. http://www.CardiologyOnline.com Cardiology Online To read more about this presentation click here to download the Word file: http://www.cardiologyonline.com/wchd13/Abstracts/PL10/3119%20Gimbel.doc PLAN TO ATTEND: International Academy of Cardiology Annual Scientific Sessions 2017 22nd World Congress on Heart Disease Vancouver, BC, Canada July 14-July 16, 2017 Congress Chairman: Asher Kimchi, M.D. http://www.CardiologyOnline.com
Views: 332 Cardiology Online

Cover letter examples simple tenses
Investment banking cover letter uk
7 eleven employment application online
Quality assurance assistant cover letter
Paper writing service online